Head of In Vivo and Hematology Research and Translation
Dr. John Leonard
Dr. John Leonard brings over 25 years of experience in the biopharmaceutical industry supporting drug discovery research and early clinical development for both small molecules and biologics. Most recently, he served as Head of Metabolic and Muscle Disease Research in Sanofi’s Rare Disease Unit, where he managed a diverse portfolio/pipeline of novel therapeutics. Before then, he served as Vice President of Small Molecule Pharmacology at Genzyme where he led research efforts focused on next generation substrate reduction therapies for rare genetic diseases. John started his industry career at Genetics Institute (later Wyeth) where his research in hematopoiesis, autoimmunity and immuno-oncology helped advance multiple programs into clinical development.
John holds a Ph.D. in Neuroimmunology from the University College London, Queen Square Institute of Neurology and a degree in Biochemistry and Pharmacology from King’s College London.
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.